Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome

被引：0
|
作者：
Abdulkadir A. Elmi
Karen Wynne
Iek L. Cheng
Despina Eleftheriou
Helen J. Lachmann
Philip N. Hawkins
Paul Brogan
机构：
[1] University College London Institute of Child Health,Infection Inflammation and Rheumatology Section
[2] Great Ormond Street Hospital NHS Foundation Trust,Department of Paediatric Rheumatology
[3] University College London National Amyloidosis Centre,undefined
来源：
Pediatric Rheumatology | / 17卷
关键词：
Canakinumab; Cryopyrin-associated periodic syndrome (CAPS); Vial-sharing; Child; Paediatric;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome
    Elmi, Abdulkadir A.
    Wynne, Karen
    Cheng, Iek L.
    Eleftheriou, Despina
    Lachmann, Helen J.
    Hawkins, Philip N.
    Brogan, Paul
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [2] Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
    Zhu, Xiaona
    Fan, Jiaqi
    Huang, Yanyan
    Xu, Yongbin
    Yang, Zhi
    Weng, Ruohang
    Luo, Ying
    Yang, Jun
    He, Tingyan
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [3] Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience
    Russo, Ricardo A. G.
    Melo-Gomes, Sonia
    Lachmann, Helen J.
    Wynne, Karen
    Rajput, Kaukab
    Eleftheriou, Despina
    Edelsten, Clive
    Hawkins, Philip N.
    Brogan, Paul A.
    RHEUMATOLOGY, 2014, 53 (04) : 665 - 670
  • [4] Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan
    Hosono, K.
    Kato, C.
    Sasajima, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1543 - 1553
  • [5] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
    Kuemmerle-Deschner J.
    Hoffman H.
    Hawkins P.N.
    van der Poll T.
    Walker U.A.
    Speziale A.
    Tilson H.H.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [6] Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients
    Yokota, S.
    Imagawa, T.
    Nishikomori, R.
    Takada, H.
    Abrams, K.
    Lheritier, K.
    Heike, T.
    Hara, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : S19 - S26
  • [7] Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results)
    Imagawa, T.
    Nishikomori, R.
    Takada, H.
    Takeshita, S.
    Patel, N.
    Kim, D.
    Lheritier, K.
    Heike, T.
    Hara, T.
    Yokota, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : 302 - 309
1